Syngene International Limited announces Q3 FY20 results Medical Dialogues Bureau25 Jan 2020 11:00 AM ISTReports 11% revenue growth in Q3 to Rs. 539 Cr
Syngene, Narayana Health, AIF launch CHAMPS- unique initiative to prevent, manage early onset of NCDs Medical Dialogues Bureau15 Aug 2019 9:30 AM ISTThe combined synergies of Narayana Health as a knowledge partner, Syngene and Biocon Foundation as funding partners and Agastya International as the...
Biocon appoints Mayank Verma as Company Secretary, Compliance Officer Farhat Nasim27 July 2019 9:00 AM ISTPrior to joining the Biocon Group, Mayank Verma has worked with ING Vysya Bank Limited from 2007 to 2012.New Delhi: Biotechnology major, Biocon has...
Biocon commercial rights on biosimilar adalimumab extends to global markets Farhat Nasim8 May 2019 9:45 AM ISTBiocon, under the terms of its global partnership with Mylan for monoclonal antibodies, retains its economic interest in this expanded in-licensing...
Syngene collaborates with BIRAC to set up Centre for Advanced Protein Studies Garima7 April 2019 9:30 AM ISTBengaluru: Syngene International Ltd., a contract research organization, announced the opening of its Centre for Advanced Protein Studies (CAPS) by...
Biocon sells 1.88 percent stake in Syngene for Rs 230 crore Ruby Khatun Khatun19 May 2018 11:00 AM ISTNew Delhi: Biocon Ltd has sold close to 2% stake in its research arm Syngene International for an estimated Rs230 crore."Biocon, the promoter of...